Midi

Midi Health is a U.S. virtual healthcare clinic for women, founded in 2021 and initially focused on perimenopause and menopause care. Patients book telehealth visits with clinicians trained in women's midlife health, who take a symptom and health history, may order labs, and produce a personalized Care Plan. Care Plans combine hormonal prescriptions (for example HRT patches, estradiol cream, vaginal estrogen, progesterone), non-hormonal prescriptions, GLP-1 medications, supplements and botanicals, lifestyle coaching, diagnostics (metabolic panels, thyroid testing, insulin sensitivity markers, hormone testing, bone density screening) and preventive care guidance. Ongoing follow-up visits and 24/7 messaging are part of the model, and the company also sells supplements and some prescription products directly, including a prescription skincare line.

The clinical scope has broadened beyond menopause to general health, weight management, metabolic and heart health (cholesterol, blood pressure, pre-diabetes), hormone and reproductive health (PCOS, fibroids, irregular periods, PMDD, contraception), mental and emotional health, urinary and vaginal health, longevity/AgeWell, and cancer survivorship. As of early 2026 the company described plans to add care lines in metabolic health, weight management, musculoskeletal health and long-term wellness, and named Medicare and Medicaid expansion as a roadmap item. Its clinician network spans OB-GYN, internal medicine, cardiology, endocrinology, survivorship, obesity, sleep, mood disorders, dermatology, longevity and naturopathic medicine.

Midi describes a proprietary AI engine used for chart analysis to personalize care journeys and support diagnosis, for automation of scheduling, triage and documentation, and for mining its women's health dataset to refine clinical protocols. Leadership includes co-founder and CEO Joanna Strober, Chief Medical Officer Kathleen Jordan MD, Chief Clinical Officer Mindy Goldman MD, President Sharon Meers, Head of Brand Innovation Jill Herzig, CTO Jake Ramanathan, CFO Jason Wheeler, CMO Melissa Waters, Chief Commercial Officer Matt Cook and Chief Health Systems Officer Ariana Chehrazi, supported by a panel of medical advisors.

Founding story

Strober founded Midi after her own experience of menopause-related symptoms — 3 a.m. wake-ups and mood swings — and finding no clear remedy at age 53. The company describes itself as founded by women for women to build care its founders needed, addressing the difficulty of finding expert clinicians and getting prescriptions covered. Strober previously founded Kurbo Health, a childhood obesity platform acquired by WW in 2018.

Business model

Direct-to-patient virtual clinic that bills health insurance for clinician visits, with self-pay options also available and no subscription fee advertised. Coverage varies by plan, so deductibles, coinsurance and copays may apply. Midi also sells supplements and prescription products directly, some after an asynchronous visit. Alongside the direct-to-patient channel it works with employers offering Midi as a workplace benefit, health systems, and benefits platforms, and is engaged with payers on cost studies.

Revenue comes from insurance-reimbursed and self-pay telehealth visits plus direct sales of supplements and prescription products; contracts with employers, health systems and benefits platforms also form part of the commercial mix.

Traction

Reported metrics include more than 230,000 patients and about 450,000 women served per company website claims, roughly 25,000 patient visits per week, a clinician network of 500 providers across 50 states, and insurance coverage reaching more than 45 million women as of February 2026. Outcome claims include 95% of patients reporting peri/menopause symptom improvement after at least two months of care, 81% reporting less severe hot flashes and night sweats, a 28-point increase in breast cancer screening adherence, an 11-point increase in colorectal screening adherence, and up to 13% lower total cost of care versus a matched comparison group. A 2024 survey of 2,200 patients reported 91% overall symptom improvement within two months.

Latest developments

On February 3, 2026 Midi announced a $100 million Series D led by Goodwater Capital with new investors Foresite Capital and Serena Ventures and continued support from Advance Venture Partners, GV, Emerson Collective, SemperVirens and McKesson Ventures, valuing the company above $1 billion. Alongside the round it named three executives: CFO Jason Wheeler (previously Tesla, Google, Forward), CMO Melissa Waters (previously Meta, Lyft, Hims & Hers) and Chief Commercial Officer Matt Cook (previously Omada Health, Firefly Health). The company said proceeds will fund technology investment, clinician hiring and new care lines in metabolic health, weight management, musculoskeletal health and longevity, with Medicare and Medicaid expansion planned. It also announced an expanded prescription skincare line and a national ad campaign, 'Midlife Back in Session,' starring Amy Schumer.